Aspirin substantially reduces hereditary colon cancer risk

December 21, 2011

A four-year study of people with a hereditary risk of colon cancer found that those who took 600mg of aspirin a day had a “substantially” lower incidence of colon cancer without any increased risk of adverse events. The anti-inflammatory effects of aspirin are a likely explanation for the effect.  Read more about this study.